Impact of a public health policy on accessibility to levodopa for people with Parkinson's disease in Brazil
Duarte, J. d. S.; Pedrosa, L. R. R.; Gomes, R. S. G.; Santos-Lobato, B. L.
Show abstract
BackgroundAccess to levodopa remains limited in many low- and middle-income countries. Brazils Popular Pharmacy Program dispenses subsidized levodopa nationwide. ObjectivesTo assess levodopa dispensing and geographic coverage of Popular Pharmacy units in Brazil. MethodsNationwide ecological study. We extracted numbers of levodopa/benserazide and carbidopa/levodopa tablets dispensed from 2020 to 2024, and derived absolute/percent change, annualized growth, and 2024 patient-equivalents of people with PD. Popular Pharmacy coverage was mapped. ResultsIn 2024, the Popular Pharmacy Program dispensed levodopa to approximately 15% of Brazilians with PD. There is a North-South gradient for levodopa dispensing through the program, with higher concentrations in the South/Southeast regions and a significant number of municipalities not dispensing levodopa in the North. ConclusionsThe Popular Pharmacy Program is consistent with increased accessibility to levodopa, yet coverage is limited and uneven. These results may guide other countries to elaborate similar health policies to increase accessibility to levodopa.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Persistent racial disparities in deep brain stimulation for Parkinson’s disease 92%
- Development of Parkinson’s disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real world cohort 91%
- α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders 91%
Similar papers in this journal
- The Australian Parkinson’s Genetics Study (APGS) - pilot (N = 1,532) 91%
- The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database 89%
- Exploring how PRIME-Parkinson care is implemented and whether, how and why it produces change, for who and under what conditions: a protocol for an embedded process evaluation within the PRIME-UK randomised controlled trial 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.